Aspergillus Clinical Trials Aspergillus RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
Conditions:   Aspergillosis Pneumonia;   Pneumocystis Pneumonia Interventions:   Diagnostic Test: Aspergillus specific proteins in exhaled breath condensate (EBC);   Diagnostic Test: Pneomocystis jirovecii DNA in exhaled breath condensate (EBC) Sponsors:   Inger Lise Gade;   Aarhus University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2020 Category: Research Source Type: clinical trials

Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
Conditions:   Aspergillosis Pneumonia;   Pneumocystis Pneumonia Interventions:   Diagnostic Test: Aspergillus specific proteins in exhaled breath condensate (EBC);   Diagnostic Test: Pneumocystis jirovecii DNA in exhaled breath condensate (EBC) Sponsors:   Inger Lise Gade;   Aarhus University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2020 Category: Research Source Type: clinical trials

An Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare Molds
Condition:   Invasive Fungal Infections Intervention:   Drug: fosmanogepix Sponsor:   Amplyx Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2020 Category: Research Source Type: clinical trials